Overview
Salaries
Products
People
Growth
Offices
Financials

Overview

MeMed is a medical technology company pioneering host-immune response diagnostics to improve infectious disease management. Its FDA-cleared MeMed BV test differentiates between bacterial and viral infections within minutes, aiding clinical decision-making and reducing unnecessary antibiotic use.

Financials

Total raised
$6.6M
Latest round
Grant
Funding rounds
3
Funding rounds
Round Announced Amount
Grant 2020 $2.7M Details
Grant 2016 $707k Details
Grant 2015 $3.2M Details